San Diego Life Sciences Roundup: MedCrypt, LunaDNA, Dynacure & More
Summary
— Cybersecurity company MedCrypt, which makes software to protect medical devices, raised a $5.3 million Series A funding round. La Jolla, CA-based LunaDNA said in December that the SEC had OK’d its plan to give equity to people who share with the company their health data, such as DNA files from 23andMe and AncestryDNA. The startup, which has raised $7.6 million since its launch, plans to use the fresh cash to accelerate research partnerships, further develop its platform, and add to its marketing team. Dynacure recently announced that UK regulators gave it the go-ahead to start a clinical trial for DYN101, an experimental treatment for centronuclear myopathies, a group of rare genetic muscle disorders. “With antisense, we believe there is an opportunity to reimagine the treatment of rare muscle-related disorders where no viable therapy exists,” said Dynacure CEO Stephane van Rooijen in a prepared statement.
Classifications
AskAI Classifications
LabelsLinked Companies
